SCHEMBL22930625

SCHEMBL22930625

Cc1cccc2c1-c1cc3c(cc1C21c2ccccc2C2(c4ccccc4-c4ccccc42)c2ccccc21)sc1ccccc13

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
MAPT P10636 4/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
POLB P06746 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PDK2 Q15119 2/20 0.35
GPR3 P46089 1/20 0.35
SLC9A1 P19634 2/20 0.34
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
PRKDC P78527 3/20 0.33
PLAU P00749 1/20 0.33
IDO1 P14902 1/20 0.32
TDO2 P48775 1/20 0.32
ALOX5 P09917 1/20 0.31
MEN1 O00255 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22930673 0.95 ALDH1A1 (0.39) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL18732177 0.85 ALDH1A1 (0.36) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL21742678 0.84 PDK2 (0.36) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL21742680 0.84 PDK2 (0.36) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL19760320 0.84 MAPT (0.47) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL20465201 0.83 ALDH1A1 (0.40) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL13467604 0.81 GPR3 (0.47) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL18732423 0.80 ALDH1A1 (0.39) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL19760330 0.80 PDK2 (0.38) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL22930728 0.80 MAPT (0.47) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10910567-B2 Double spiro-type compound and organic light emitting diode comprising same LG CHEM, LTD. 2021-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10910567-B2 Double spiro-type compound and organic light emitting diode comprising same NR2E3, ALDH1A2, CRY1 ALDH1A1 35/4885MAPT 1561/4885HPGD 2182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.